Breaking: White House unveils sweeping plan to lower U.S. drug prices

The actions are far more aggressive than those in President Trump's first term

Log In    Subscribe BREAKING NEWS   White House unveils sweeping plan to try to lower U.S. drug prices By Daniel Payne Alex Brandon/AP The Trump administration on Monday unveiled an aggressive, sweeping plan to try to lower prescription drug prices. The strategy is intended to push drugmakers to make a deal with the administration or face consequences from agencies across the federal government.  READ MORE Sign up for D.C. Diagnosis The latest updates in federal health agencies, research institutes, and U.S. policy. Learn more. In Case You Missed It House GOP unveils plans to reshape Medicaid By John Wilkerson Amid the Milwaukee lead crisis, a laid-off CDC scientist volunteered his expertise. It wasn't so simple By Eric Boodman Chinese and Chinese-American researchers in the U.S. confront a perilous moment By Brian Yang Trump signs order in bid to boost pharma manufacturing in the U.S. By Ed Silverman Don't miss out on another STAT Investigation Unlock the world of health and medicine with a subscription to STAT+ Learn more STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us